A retrospective analysis of the role of proton pump inhibitors on colorectal cancer disease survival.

被引：0
|
作者：
Ramjeesingh, Ravi
Graham, Cassandra
Orr, Christine
Bricks, Corey Sean
Hopman, Wilma M.
Hammad, Nazik
机构：
[1] Queens Univ, Dept Oncol, Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[2] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14517
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer
    Wang, Xiaoyu
    Liu, Chun
    Wang, Jiaqi
    Fan, Yue
    Wang, Zhenghua
    Wang, Yuanyuan
    ONCOTARGET, 2017, 8 (35) : 58801 - 58808
  • [22] Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer
    Wong, Grace G.
    Ha, Vincent
    Chu, Michael P.
    Dersch-Mills, Deonne
    Ghosh, Sunita
    Chambers, Carole R.
    Sawyer, Michael B.
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : 72 - 79
  • [23] PROTON PUMP INHIBITORS AND RISK OF GASTRIC CANCER: A RETROSPECTIVE COHORT STUDY
    Choi, J.
    Hong, K. S.
    Kang, S. J.
    Kim, J. S.
    HELICOBACTER, 2013, 18 : 111 - 111
  • [24] THE ROLE OF PROTON PUMP INHIBITORS IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
    BARDHAN, KD
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1995, 9 : 15 - 25
  • [25] Gastroesophageal reflux disease and asthma - The role of proton pump inhibitors
    Menon, MS
    Al-Hajji, M
    Morice, A
    CHEST, 2006, 129 (06) : 1732 - 1732
  • [26] Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
    Yoshiko Kitazume
    Hitoshi Kawazoe
    Ryuji Uozumi
    Tomoe Yoshizawa
    Hirotoshi Iihara
    Hironori Fujii
    Masaya Takahashi
    Takahiro Arai
    Yasushi Murachi
    Yumiko Sato
    Takahiro Mikami
    Koji Hashiguchi
    Tomoko Yamazaki
    Katsuyuki Takahashi
    Yukiyoshi Fujita
    Yuki Hosokawa
    Issei Morozumi
    Masami Tsuchiya
    Atsushi Yokoyama
    Hironobu Hashimoto
    Masakazu Yamaguchi
    Scientific Reports, 12
  • [27] Aromatase inhibitors and metastatic breast cancer survival.
    Abrial, C
    Leheurteur, M
    Cabrespine, A
    Mouret-Reynier, MA
    Durando, X
    Ferrière, JP
    Kwiatkowski, F
    Penault-Llorca, F
    Curé, H
    Chollet, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 69S - 69S
  • [28] Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis
    Guo, Huizhu
    Zhang, Ruiqiu
    Zhang, Pei
    Chen, Zhaoyang
    Hua, Yuqing
    Huang, Xin
    Li, Xiao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] PROTON PUMP INHIBITORS DO NOT INCREASE THE RISK OF COLORECTAL CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS
    Kamal, Faisal
    Khan, Muhammad Ali
    Sharma, Sachit
    Imam, Zaid
    Jowhar, Dawit
    Henry, Collin
    Zafar, Muhammad Usman
    Petryna, Ellen
    Sami, Khadija N.
    Iqbal, Umair
    Esswein, Julia
    Howden, Colin W.
    GASTROENTEROLOGY, 2021, 160 (06) : S603 - S604
  • [30] Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies
    Tianyi Ma
    Meng Wu
    Shengnan Jia
    Lanlan Yang
    International Journal of Colorectal Disease, 2020, 35 : 2157 - 2169
12345